Diabetic ulcer is associated with metabolism, whereas lower extremity ulcer is associated with nutrition in the body.

For roentgen ulcer, nobody can deal with it except MEBO.

Our solution to the problem is regeneration.

Although the skin is ulcerative, the tissues underneath the wound bed still retain a potential to regenerate. 

We created regeneration of wound by providing our regenerative energy source and by exploiting the regenerative cells at the wound site. Of course, we will further explore the characteristics of such regenerative cells and to find out the differences between these cells and normal cells. 

Interestingly, these cells on the ulcer wound do not absorb normal energy or nutrients, but they could still regenerate to heal the wound. These results revealed many interesting aspects that are worth our further exploration. We are quite sure that the metabolism at the wound site is different from normal metabolism. 

To give you an example here. As you know, trauma patients who suffered from hepatophyma due to severe malnutrition have to be salvaged by injection of fat emulsion so as to provide energy to the body.

Thus the source of the energy is not dependent on insulin as glucose needs insulin whereas fat emulsion does not. 

This is illuminating. MEBO also discovered that the regenerative cells obtain energy via uptake by absorption. 

We can say that in the body, providing energy via absorption of fat emulsion opens up a metabolic channel independent from insulin. 

While many regard the treatment of diabetic ulcers a major challenge, to us it is quite easy to tackle. 

Johnson & Johnson spent hundreds of millions to develop a new drug, which could only deal with diabetic ulcer with wound size below 5 centimeters in diameter and the efficacy is only 40%, which is way below the efficacy we achieved using MEBO regenerative therapy.

While these 3 kinds of surface ulcers are considered as major medical challenges in the world, clinically we demonstrated that these 3 ulcers can heal through regeneration. 

For roentgen ulcer, when we applied MEBO Wound Ointment to the wound, new skin starts to grow. 

As revealed later, in our mechanistic studies of cancer cells, MEBO regenerative substances act directly on the cells by entering into the inside of the cell, not on the surface of the cell membrane. 

Above all this, what we achieved brings great hopes to many patients. 

Diabetic ulcer is one of the complications of diabetes. 

Insufficient blood-supply caused by pathological changes in skin arteriola could lead to local skin cyanosis or ischemic ulcer. 

The ulcer wound is shallow and painful and mostly occurs in foot region. 

In ischemic condition, neurathophy and trauma could lead to malnutritional skin ulcer and it normally happens in foot region. 

The ulcer wound is deep and no pain feeling and also it is difficult to heal. 

Skin ulcer is always complicated by infections, which could cause insecondary pyogenic osteomyelitis.

In later part, you can see how a new medicine-Moist Exposed Burn Ointment (MEBO) effectively treats body surface ulcers.